Added to YB: 2021-02-19
Pitch date: 2021-02-19
SLNO [bullish]
Soleno Therapeutics, Inc.
+17.36%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Market Cap
$2.8B
Pitch Price
$45.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
24.71
P/E
29.97
EV/Sales
8.02
Sector
Biotechnology
Category
N/A
Show full summary:
SOLENO THERAPEUTICS INC SLNO
A summary for this pitch has not been created yet.
Read full article (0 min)